Net income
5Y CAGR −8.8%10Y CAGR +6.2%No quarters filed for this figure.
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Bar = where today’s multiple sits in SNY’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
No quarters filed for this figure.
No quarters filed for this figure.
No quarters filed for this figure.
FY25: operating cash flow $12.2B, capex −$4B
No quarters filed for this figure.
No quarters filed for this figure.
No quarters filed for this figure.
Sanofi ADR is an American Depositary Receipt representing shares of Sanofi, a global healthcare company focused on pharmaceuticals and vaccines. Through its ADR program, U.S. investors can access the company’s ordinary shares in a form that is traded in the United States, while the underlying business remains centered in France. Sanofi develops, manufactures, and commercializes prescription medicines across several therapeutic areas, including specialty care, general medicines, and immunology, and it also operates a major vaccines business. The company serves patients, healthcare providers, and public health systems in markets around the world, with products used in chronic, rare, and infectious diseases. Sanofi ADR reflects the company’s broad role in the global biopharmaceutical market, combining research, production, and distribution capabilities with a diversified healthcare portfolio.
Paris, France·74,846 employees·Drug Manufacturers - General·sanofi.com·As of Oct 28, 2026
No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.
All filings and insider trades →| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +24.07% | +0.61% |
| JNJ | Johnson & Johnson | +7.92% | +3.81% |
| ABBV | AbbVie Inc. | +12.18% | +3.09% |
| MRK | Merck & Co. Inc. | +4.20% | +3.93% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +10.08% | +1.22% |
| NVS | Novartis AG | +17.01% | +3.59% |
| TMO | Thermo Fisher Scientific Inc. | +7.84% | +1.12% |
| AMGN | Amgen Inc. | +18.69% | +3.71% |